TEL: (888) 907-0115
Venus Concept is a leader in the global medical and aesthetic device market, pairing best-in-class technology with the first and only true subscription model in the industry.
Venus Bliss MAX™ is an advanced three-in-one solution for body treatments. The workstation targets fat, muscle, and skin with three distinct technologies in an effective and comfortable manner, maximizing results and patient satisfaction by tailoring the right modality for each indication.
Three powerful technologies – 1064 nm diode laser for non-invasive lipolysis, electrical muscle stimulation (EMS) for muscle toning, and proprietary (MP)2 technology for skin and cellulite.
Effective and comfortable – Diode lasers are equipped with advanced safety features & contact cooling, FlexMAX offers adaptive algorithms & adjustable parameters, and (MP)2 provides real-time thermal feedback.
Proven patient demand and revenue potential - IoT collects treatment and demographic information that will help providers with optimizing their business practices and provide clinical insights for improved ROI.
In addition to the three best-in-class technologies, Venus Bliss MAX™ is also equipped with additional features that can improve ease-of-use for operators and clinical outcomes for patients.
Energy is powerfully delivered to the subcutaneous tissue with a maximum energy output of 1.4 W/cm2 while cooling mechanisms continuously chill the skin. Four 1064 nm diode laser applicators with 36 cm2 spot size cover 50% more treatment area than other non-invasive laser lipolysis systems. Each applicator can be activated individually and placed in various configurations on a belt for hands-free operation.
Engineered to deliver electrical pulses in a controlled and accurate manner, the FlexMAX applicators feature a duo electrode design that contains the flow of energy. Differing from magnetic technologies, EMS enables a targeted delivery to the muscle nerves from one electrode to the other, causing involuntary contractions. For different configurations and coverage over the targeted muscle area, each of the 4 applicators can be individually activated or used together.
Setting itself apart from monopolar and bipolar modalities, Multi-Polar Radio Frequency is regarded as the more versatile option for improved efficacy and patient comfort. This modality is designed to distribute heat more homogeneously, reaching therapeutic temperatures quickly, and enabling a very comfortable treatment and consistent results. For a greater effect on cellulite and efficient treatment of large body areas, the eight electrodes are spaced 7.5 cm apart, allowing the heat to reach all layers of the dermis.
Venus Bliss MAX™ is equipped with an advanced connectivity module, enabling "Internet of Things" (IoT) capability - the latest data collection technology to enhance business operations. IoT collects treatment and demographic information that will help providers with optimizing their business practices and provide clinical insights.
Venus Bliss MAX™ features an intuitive User Interface (UI) that clearly displays every parameter the operator needs to deliver safe and effective treatments for each of the three modalities. Applicator contact and status signals are included on the diode laser screen, specific programs are built for each body muscle and its associated combinations under the FlexMAX mode, while ATC and a real-time temperature graph are on the (MP)2 screen. All in all, its simplistic design and easy-to-follow navigation allow for effortless customization and operator control during the treatment.
Target fat, muscle, and skin effectively and comfortably. Maximize results and patient satisfaction by tailoring the right modality for each indication.
Gold Standard for Fat Reduction
Venus Bliss MAX™ diode laser technology delivers effective, comfortable, and efficient non-invasive laser lipolysis treatments by heating the entire targeted subcutaneous layer to the treatment temperature unlike other thermal fat reduction technologies. The 1064 nm wavelength is optimal for penetrating into the adipose tissue layer, with homogeneous energy distribution capabilities. Extended heating cycles elevate the targeted fat layer temperature to 42-46ºC, effectively damaging and destroying fat cells in just 25 minutes per treatment. The apoptotic fat cells are then eliminated through the body’s lymphatic system over time.
Best-In-Class Electrical Muscle Stimulation Machine
The FlexMAX EMS modality offers an unprecedented solution to the muscle category. Controlled and precise energies are delivered uniquely to muscle groups via best-in-class electrical muscle stimulation. The muscles are safely activated without heating the surrounding tissue. Paired with specific pulse durations by muscle group, performance-informed smart training programs and advanced adaptive algorithms, each treatment is fully personalized and mimics a real training session that can build intensity over time. FlexMAX EMS enables effective and comfortable treatment programs regardless of the patients’ fitness level, resulting in stronger and more defined muscle appearance.
Patented (MP)² Technology with Proven Results
(MP)2 technology represents an innovative combination of Multi-Polar Radio Frequency (RF) and Pulsed Electro Magnetic Fields (PEMF) to yield synergistic effects during treatments. This patented technology can reduce cellulite for smoother, firmer-looking areas while also resulting in tighter skin appearance. This is a proven, comfortable treatment with high customer satisfaction (92% clinical reliability rating)1 and more than 12,000 units installed globally.
Light Source |
Diode Laser |
Wavelength |
1064 ± 10 nm |
Max. Power |
50 W per applicator, 200 W in total |
Power Density |
Up to 1.4 watts/cm2 |
Spot Size |
36 cm2 (6 cm x 6 cm) |
Output Waveform |
Symmetrical Biphasic |
Pulse Width |
500 – 2500 μSec |
Pulse Frequency |
1 - 1000 Hz |
Output Channel Type |
Synchronous |
Max. RF Output Power |
150 Watts |
Output RF Frequency |
1 MHz |
Constant Magnetic Field |
15 Gauss |
Magnetic Pulse Frequency |
15 Hz |
Suction Levels |
4 |
Treatments work to destroy fat cells in the abdomen, resulting in a flatter midsection.
Devices that offer lipolysis: Venus Bliss™
Results after: 1 treatment
Courtesy of Laser & Skin Surgery Center of Northern California, Suzanne Kilmer, MD
Research has shown a significant reduction in adipose layer thickness of the flanks when measured by ultrasound 12 weeks after treatment4.
Devices that offer lipolysis: Venus Bliss™
Results after: 1 treatment
Courtesy of Laser & Skin Surgery Center of Northern California, Suzanne Kilmer, MD
Treatments on the abdomen and/or flanks work to reduce focal fat to provide a midsection with a narrower circumference and contoured silhouette.
Devices that offer lipolysis: Venus Bliss™
Results after: 1 treatment
Courtesy of Laser & Skin Surgery Center of Northern California, Suzanne Kilmer, MD
Treatments work to destroy fat cells in the abdomen, resulting in a flatter midsection.
Devices that offer non-invasive lipolysis: Venus Bliss™
Results after: 2 Fat and 2 Skin Tightening Treatments
Courtesy of Ultra Body Sculpt
Authors: Mikaela Kislevitz, MD, BSN, RN, Christine Wamsley, BA, Alison Kang, MD, Suzanne Kilmer, MD, John Hoopman, CMLSO, Jennifer Barillas, BS, Jeffrey M Kenkel, MD
Publication: Aesthetic Surgery Journal
Published Date: February 2021
INDICATIONS FOR USE:
*The Venus Bliss MAX™ system includes 3 unique technologies. The diode laser applicators are cleared by the FDA for non-invasive lipolysis of the abdomen, flanks, back, and thighs in individuals with a BodyMass Index (BMI) of 30 or less. The (MP)2 applicator is for improvement of local blood circulation and temporary reduction of cellulite. The FlexMAX applicators are intended for muscle conditioning to stimulate healthy muscles.↩
REFERENCES:
For more information call: (888) 907-0115 // info@venusconcept.com // 1880 N Commerce Parkway, Suite 2, Weston, FL, 33326 United States
REGULATORY CLEARANCES [ More ]
Venus Bliss™ is cleared by the FDA for non-invasive lipolysis of the abdomen and flanks in individuals with a Body Mass Index (BMI) of 30 or less, with the diode laser applicators. The (MP)2 applicator is cleared by the FDA for temporary reduction in the appearance of cellulite.
Venus Versa™ is cleared by the FDA as a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 applicators are cleared by the FDA for the treatment of benign pigmented epidermal and cutaneous lesions and treatment of benign cutaneous vascular lesions. The HR650/HR650XL and HR690/HR690XL applicators are cleared by the FDA for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for Fitzpatrick skin types I-IV. The AC Dual applicator is cleared by the FDA for the treatment of acne vulgaris. The DiamondPolar™ and OctiPolar™ applicators on the Venus Versa™ system are cleared by the FDA for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The NanoFractional RF™ (Viva) applicator is cleared by the FDA for dermatological procedures requiring ablation and resurfacing of the skin.
ARTAS iX™ is cleared by the FDA with indication for use for harvesting hair follicles from the scalp in men diagnosed with androgenic alopecia (male pattern hair loss) who have black or brown straight hair. ARTAS iX™ is intended to assist physicians in identifying and extracting hair follicular units from the scalp during hair transplantation; creating recipient sites; and implanting harvested hair follicles.
NeoGraft® is cleared by the FDA with indication for use in suction-assisted follicular extraction and re-implantation. NeoGraft® is an auto-graft system and can be used on both male and female patients.
Venus Legacy™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV with the OctiPolar™ and DiamondPolar™ applicators, and temporary reduction in the appearance of cellulite with the 4D Body (LB2) and 4D Face (LF2) applicators.
Venus Velocity™ is cleared by the FDA for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae, for all Fitzpatrick skin types.
The Venus Viva™ MD is cleared by the FDA for the use in dermatological procedures requiring ablation and resurfacing of the skin, and the non-invasive treatment of moderate to severe facial wrinkles and rhytides for females in Fitzpatrick skin types I-IV with the DiamondPolar™ applicator.
Venus Freeze Plus™ is a non-invasive device cleared by the FDA for use in dermatologic and general surgical procedures for females for the treatment of moderate to severe facial wrinkles and rhytides in Fitzpatrick skin types I-IV, using the DiamondPolar™ and OctiPolar™ applicators.
Venus Heal™ is cleared by the FDA for the relief of minor muscle aches and pain, relief of muscle spasm, and temporary improvement of local blood circulation. The treatment of these conditions will lead to the treatment of certain soft tissue injuries and conditions.
Venus Glow™ is cleared by the FDA as a Class I motorized dermabrasion device. It provides a dermal rejuvenation treatment that works to open up and deep-clean pores. Venus Concept is the exclusive distributor for Venus Glow™.
Venus Epileve™ is cleared by the FDA for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs
re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae for all Fitzpatrick skin types.
Copyright © 2020 Venus Concept. All rights reserved.
You are entering our website. For other countries/regions and language options, please click the SELECT A DIFFERENT REGION button below.
SELECT A DIFFERENT REGIONAre you looking to get a treatment? Please visit our patient website to learn more.
Click HereBe aware of schemes involving fraudulent job postings.
Read More